The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Patients with cancer want information and advice early in the disease course about how to deal with the financial stressors ...

Exchange-traded funds, commonly known as ETFs, are security baskets where a collection of investments is pooled. Like stocks, ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

From doctors' offices to family gatherings, larger-bodied people report being bombarded with unsolicited advice about their ...

The World Health Organization has called on countries in South-East Asia Region to tackle the obesity crisis and its related ...

Why Corbus Pharmaceuticals sees Novo Nordisk’s controversial approach to obesity drugs as a ticket to a blockbuster.

'Bachelor' alum Joey Graziadei and pro Jenna Johnson chat with THR after the premiere of 'Dancing With the Stars' and dish on ...